B-cell prolymphocytic leukemia natural history, complications and prognosis

Revision as of 14:27, 7 October 2015 by Carlos Lopez (talk | contribs)
Jump to navigation Jump to search

B-cell prolymphocytic leukemia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating B-cell prolymphocytic leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

B-cell prolymphocytic leukemia natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of B-cell prolymphocytic leukemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on B-cell prolymphocytic leukemia natural history, complications and prognosis

CDC on B-cell prolymphocytic leukemia natural history, complications and prognosis

B-cell prolymphocytic leukemia natural history, complications and prognosis in the news

Blogs on B-cell prolymphocytic leukemia natural history, complications and prognosis

Directions to Hospitals Treating B-cell prolymphocytic leukemia

Risk calculators and risk factors for B-cell prolymphocytic leukemia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Carlos A Lopez, M.D. [2]

Overview

The prognosis for B-cell prolymphocytic leukemia is generally poor.

Prognosis

The prognosis for B-cell prolymphocytic leukemia is generally poor. But usually has a better prognosis than T-cell prolymphocytic leukemia.[1][2].

References

  1. Del Giudice I, Davis Z, Matutes E; et al. (2006). "IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL)". Leukemia. 20 (7): 1231–7. doi:10.1038/sj.leu.2404238. PMID 16642047.
  2. "Canadian Cancer Society".